[1-(2-hydroxyethyl)-1,2,4-triazole esters].

B. Lablanche,J. Hénichart,R. Houssin,J. Navarro,A. Pério,E. Vallée

DOI: https://doi.org/10.1002/CHIN.197824224

1977-11-01

Annales Pharmaceutiques Françaises

Abstract:

What problem does this paper attempt to address?

LSC - 2024 - Epigenetic age acceleration and severity of airflow limitation on blood and lung tissue of COPD

Viglino,J.,Casas-Recasen,S.,Olvera,N.,Garcia,T.,Agusti,A.,Faner,R.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa4384

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Background: Accelerated lung ageing has been proposed as a mechanism of chronic obstructive lung disease (COPD). Yet, whether the aging markers in lung tissue and blood in COPD patients are similar or if they change with the severity of airflow limitation is unclear. This study sought to explore these questions using DNA methylation-based aging calculation algorithms (i.e. epigenetic clocks), previously developed to measure the biological age of a variety of tissues. Methods: DNA was extracted from blood (n=168) and lung tissue (n=138) of COPD patients with different degrees of airflow limitation severity (FEV1% ref.). Genome wide DNA methylation was assessed with EPIC arrays (Illumina), and the biological age and age acceleration was computed with 7 epigenetic clocks, and with the mDNA-TL estimator (a Telomere length shortening measure). Multivariable linear regressions adjusted for chronological age, sex, pack-year and smoking status, were used for the analysis. Results: In blood, airflow limitation severity was associated with the biological age acceleration determined by three epigenetic clocks (BLUP, Levine, DunedinPACE) and by the mDNA-TL estimator. By contrast, in lung tissue only the mDNA-TL estimator showed a significant association with the severity of airflow limitation. Conclusions: COPD patients with more severe airflow limitation present a higher biological epigenetic age acceleration only in blood. However, both blood and lung tissue of these patients present an accelerated Telomere shortening. These findings suggest that the pace of aging biomarkers is different in the two tissues.

respiratory system
Epigenetic blood biomarkers of ageing and mortality in COPD

Ana I. Hernandez Cordero,Chen Xi Yang,Stephen Milne,Xuan Li,Zsuzsanna Hollander,Virginia Chen,Raymond Ng,Scott J. Tebbutt,Janice M. Leung,Don D. Sin

DOI: https://doi.org/10.1183/13993003.01890-2021

IF: 24.3

2021-09-24

European Respiratory Journal

Abstract:COPD is an age-related condition that is linked to cellular senescence [1]. In COPD, contributors to cellular senescence include oxidative stress from environmental factors, such as cigarette smoking and persistent lung inflammation [2]. These factors can also augment replicative senescence, which is characterised by progressive telomere attrition, ultimately leading to cell cycle arrest and death. Patients with COPD have shorter telomeres [3] and faster rates of telomere attrition [4] compared to controls; however, the clinical impact of cellular or replicative senescence in COPD remains uncertain.

respiratory system
The Blood DNA Methylation Clock GrimAge Is a Robust Surrogate for Airway Epithelia Aging

Ana I. Hernandez Cordero,Chen Xi Yang,Xuan Li,Julia Yang,Tawimas Shaipanich,Julie L. MacIsaac,David T. S. Lin,Michael S. Kobor,Steve Horvath,Shu Fan Paul Man,Don D. Sin,Janice M. Leung

DOI: https://doi.org/10.3390/biomedicines10123094

IF: 4.757

2022-12-02

Biomedicines

Abstract:One key feature of Chronic Obstructive Pulmonary Disease (COPD) is that its prevalence increases exponentially with age. DNA methylation clocks have become powerful biomarkers to detect accelerated aging in a variety of diseases and can help prognose outcomes in severe COPD. This study investigated which DNA methylation clock could best reflect airway epigenetic age when used in more accessible blood samples. Our analyses showed that out of six DNA methylation clocks investigated, DNAmGrimAge demonstrated the strongest correlation and the smallest difference between the airway epithelium and blood. Our findings suggests that blood DNAmGrimAge accurately reflects airway epigenetic age of individuals and that its elevation is highly associated with COPD.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Epigenome-wide Gene–age Interaction Analysis Reveals Reversed Effects of PRODH DNA Methylation on Survival Between Young and Elderly Early-Stage NSCLC Patients

Chao Chen,Yongyue Wei,Liangmin Wei,Jiajin Chen,Xin Chen,Xuesi Dong,Jieyu He,Lijuan Lin,Ying Zhu,Hui Huang,Dongfang You,Linjing Lai,Sipeng Shen,Weiwei Duan,Li Su,Andrea Shafer,Thomas Fleischer,Maria Moksnes Bjaanaes,Anna Karlsson,Maria Planck,Rui Wang,Johan Staaf,Aslaug Helland,Manel Esteller,Ruyang Zhang,Feng Chen,David C. Christiani

DOI: https://doi.org/10.18632/aging.103284

2020-01-01

Aging

Abstract:DNA methylation changes during aging, but it remains unclear whether the effect of DNA methylation on lung cancer survival varies with age. Such an effect could decrease prediction accuracy and treatment efficacy. We performed a methylation-age interaction analysis using 1,230 early-stage lung adenocarcinoma patients from five cohorts. A Cox proportional hazards model was used to investigate lung adenocarcinoma and squamous cell carcinoma patients for methylation-age interactions, which were further confirmed in a validation phase. We identified one adenocarcinoma-specific CpG probe, cg14326354(PRODH), with effects significantly modified by age (HRinteraction = 0.989; 95% CI: 0.986-0.994; P = 9.18x10-7). The effect of low methylation was reversed for young and elderly patients categorized by the boundary of 95% CI standard (HRyoung = 2.44; 95% CI: 1.26-4.72; P = 8.34x10-3; HRelderly = 0.58; 95% CI: 0.42-0.82; P = 1.67x10-3). Moreover, there was an antagonistic interaction between low cg14326354(PRODH) methylation and elderly age (HRinteraction = 0.21; 95% CI: 0.11-0.40; P = 2.20x10-6). In summary, low methylation of cg14326354PRODH might benefit survival of elderly lung adenocarcinoma patients, providing new insight to age-specific prediction and potential drug targeting.
Cell-free DNA levels associate with COPD exacerbations and mortality

Sarah A. Ware,Corrine R. Kliment,Luca Giordano,Kevin M. Redding,William L. Rumsey,Stewart Bates,Yingze Zhang,Frank C. Sciurba,S. Mehdi Nouraie,Brett A. Kaufman

DOI: https://doi.org/10.1186/s12931-023-02658-1

IF: 5.8

2024-01-18

Respiratory Research

Abstract:Abstract The question addressed by the study Good biological indicators capable of predicting chronic obstructive pulmonary disease (COPD) phenotypes and clinical trajectories are lacking. Because nuclear and mitochondrial genomes are damaged and released by cigarette smoke exposure, plasma cell-free mitochondrial and nuclear DNA (cf-mtDNA and cf-nDNA) levels could potentially integrate disease physiology and clinical phenotypes in COPD. This study aimed to determine whether plasma cf-mtDNA and cf-nDNA levels are associated with COPD disease severity, exacerbations, and mortality risk. Materials and methods We quantified mtDNA and nDNA copy numbers in plasma from participants enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE, n = 2,702) study and determined associations with relevant clinical parameters. Results Of the 2,128 participants with COPD, 65% were male and the median age was 64 (interquartile range, 59–69) years. During the baseline visit, cf-mtDNA levels positively correlated with future exacerbation rates in subjects with mild/moderate and severe disease (Global Initiative for Obstructive Lung Disease [GOLD] I/II and III, respectively) or with high eosinophil count (≥ 300). cf-nDNA positively associated with an increased mortality risk (hazard ratio, 1.33 [95% confidence interval, 1.01–1.74] per each natural log of cf-nDNA copy number). Additional analysis revealed that individuals with low cf-mtDNA and high cf-nDNA abundance further increased the mortality risk (hazard ratio, 1.62 [95% confidence interval, 1.16–2.25] per each natural log of cf-nDNA copy number). Answer to the question Plasma cf-mtDNA and cf-nDNA, when integrated into quantitative clinical measurements, may aid in improving COPD severity and progression assessment.

respiratory system
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease

Ana I. Hernández Cordero,Chen Xi Yang,Xuan Li,Stephen Milne,Virginia Chen,Zsuzsanna Hollander,Raymond Ng,Gerard J. Criner,Prescott G. Woodruff,Stephen C. Lazarus,John E. Connett,MeiLan K. Han,Fernando J. Martinez,Robert M. Reed,S. F. Paul Man,Janice M. Leung,Don D. Sin

DOI: https://doi.org/10.1186/s12931-021-01911-9

IF: 5.8

2021-12-01

Respiratory Research

Abstract:Abstract Background Chronic obstructive pulmonary disease (COPD) is an age-related condition that has been associated with early telomere attrition; the clinical implications of telomere shortening in COPD are not well known. In this study we aimed to determine the relationship of the epigenetic regulation of telomeric length in peripheral blood with the risk of exacerbations and hospitalization in patients with COPD. Methods Blood DNA methylation profiles were obtained from 292 patients with COPD enrolled in the placebo arm of the Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated with Chronic Obstructive Pulmonary Disease (MACRO) Study and who were followed for 1-year. We calculated telomere length based on DNA methylation markers (DNAmTL) and related this biomarker to the risk of exacerbation and hospitalization and health status (St. George Respiratory Questionnaire [SGRQ]) score over time using a Cox proportional hazards model. We also used linear models to investigate the associations of DNAmTL with the rates of exacerbation and hospitalization (adjusted for chronological age, lung function, race, sex, smoking, body mass index and cell composition). Results Participants with short DNAmTL demonstrated increased risk of exacerbation ( P = 0.02 ) and hospitalization ( P = 0.03 ) compared to those with longer DNAmTL. DNAmTL age acceleration was associated with higher rates of exacerbation ( P = 1.35 × 10 –04 ) and hospitalization ( P = 5.21 × 10 –03 ) and poor health status (lower SGRQ scores) independent of chronological age ( P = 0.03 ). Conclusion Telomeric age based on blood DNA methylation is associated with COPD exacerbation and hospitalization and thus a promising biomarker for poor outcomes in COPD.

respiratory system
The influence of chronic inflammation in COPD patients aged 40 to 60 years on the early development of atherosclerotic changes in brachiocephalic vessels.

Batashova-Halinska,V.,Andrusyshyna,I.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa4330

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:In this work we wanted to study of the relationship between chronic inflammation in COPD and the possibility of developing atherosclerosis of brachiocephalic vessels in patients aged 40-60 years. We analized 66 disease histories of COPD patients aged 40-60 years. The average age of the patients was 51.16 ± 5.01 years. The majority of patients with a stable course of COPD, key markers of systemic inflammation were higher than in the comparison group — C-reactive protein by 1.86 mg, fibrinogen by 0.37 g/l, TNF- α by 2.64 mg/l. The expressiveness of the inflammatory response in patients with COPD progressively increases as the disease progresses. We took the CRP level as a basic indicator of systemic inflammation. The average level of CRP in patients that we researched was 11.60 ± 5.54 mg/l. We also considered some of the indicators of high risk of developing atherosclerosis, such as low-density lipoprotein (LDL) and total cholesterol, and analyzed the dependence of these indicators on CRP levels. Correlation coefficient y = 0.6838x + 4.7487(CPR and total cholesterol) Correlation coefficient y = 0.7749x + 3.4863(CRP anf LDL) The correlation between CRP and LDL is even stronger than between CRP and total cholesterol - r = 0.77 ± 3.48), which indicates a strong dependence. Therefore, looking at these data, it is possible to assume that patients with COPD, as a chronic inflammation, which is accompanied by an increased level of CRP, it makes sense to screen the levels of total cholesterol and LDL in order to prevent or as soon as possible diagnose the risk of developing atherosclerosis of vessels, as one of the leading causes of death.

respiratory system
Neutrophil-to-Lymphocyte Ratio, Lung Function, COPD, and AHRR Hypomethylation in Older Adults: A 30-Year Longitudinal Study of US Veterans

Xu Gao,Brent Coull,Xihong Lin,Pantel Vokonas,Lifang Hou,Dawn L DeMeo,Augusto A Litonjua,Joel D Schwartz,Andrea A Baccarelli

DOI: https://doi.org/10.2139/ssrn.3514776

2019-01-01

Abstract:Background: Chronic obstructive pulmonary disease (COPD) is a critical public health burden. The neutrophil-to-lymphocyte ratio (NLR) is an inflammation biomarker and predictor for COPD morbidity and mortality; however, its associations with lung function decline and COPD development are incompletely understood.Methods: We performed a longitudinal study of US veterans with> 30 years of follow-up to investigate the associations of NLR with lung function, COPD, and the hypomethylation of cg05575921, the top DNA methylation marker of lung function changes in response to tobacco smoking. This study included 7466 visits from 1549 white males each examined up to 13 times during 1982-2018. NLR was estimated based on automated whole blood cell counts, and cg05575921 profile was measured in blood DNA using Illumina 450K BeadChip from a subset of 1228 visits.Findings: A one-unit increase in NLR was associated with a 0∙ 021-liter, 0∙ 016-liter, 0∙ 29%, and 3∙ 7-liters/min lower FEV1, FVC, FEV1/FVC, and MMEF, respectively (p-values< 0∙ 001). NLR changes up to~ 10 years were robustly associated with corresponding longitudinal changes in lung function. Further, this increase in NLR was associated with 9% higher odds of COPD (95% CI: 1∙ 03-1∙ 15) and 27% higher risk of incident COPD (95% CI: 1∙ 07-1∙ 51). NLR was associated with cg05575921 hypomethylation, which may mediate the adverse effect of NLR-related inflammation on lung function. Applying NLR and cg05575921 in combination could classify the extent of lung function impairment and COPD risk.Interpretation: NLR may be a valuable biomarker to promote …
Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies

Miyuki Breen,Jamaji C Nwanaji-Enwerem,Stefan Karrasch,Claudia Flexeder,Holger Schulz,Melanie Waldenberger,Sonja Kunze,Markus Ollert,Stefan Weidinger,Elena Colicino,Xu Gao,Cuicui Wang,Jincheng Shen,Allan C Just,Pantel Vokonas,David Sparrow,Lifang Hou,Joel D Schwartz,Andrea A Baccarelli,Annette Peters,Cavin K Ward-Caviness,Jamaji C. Nwanaji-Enwerem,Allan C. Just,Joel D. Schwartz,Andrea A. Baccarelli,Cavin K. Ward-Caviness

DOI: https://doi.org/10.18632/aging.103784

2020-08-03

Aging

Abstract:Chronic obstructive pulmonary disease (COPD) is a frequent diagnosis in older individuals and contributor to global morbidity and mortality. Given the link between lung disease and aging, we need to understand how molecular indicators of aging relate to lung function and disease. Using data from the population-based KORA (Cooperative Health Research in the Region of Augsburg) surveys, we associated baseline epigenetic (DNA methylation) age acceleration with incident COPD and lung function. Models were adjusted for age, sex, smoking, height, weight, and baseline lung disease as appropriate. Associations were replicated in the Normative Aging Study. Of 770 KORA participants, 131 developed incident COPD over 7 years. Baseline accelerated epigenetic aging was significantly associated with incident COPD. The change in age acceleration (follow-up - baseline) was more strongly associated with COPD than baseline aging alone. The association between the change in age acceleration between baseline and follow-up and incident COPD replicated in the Normative Aging Study. Associations with spirometric lung function parameters were weaker than those with COPD, but a meta-analysis of both cohorts provide suggestive evidence of associations. Accelerated epigenetic aging, both baseline measures and changes over time, may be a risk factor for COPD and reduced lung function.
The occurrence of tubercle bacilli resistant to P-aminosalicylic acid.

A. G. Karlson,A. Dalaude

DOI: https://doi.org/10.1378/CHEST.16.6.667

1949-12-01

Diseases of the Chest

Abstract:One hundred and two cultures of human-type tubercle bacilli from patients who had not received PAS were found to be resistant to 0.018 mg. of PAS per 100 ml. of egg-yolk agar but not to 0.072 mg. Four cultures were resistant to 0.072 mg. and one to 0.144 mg. per 100 ml. of the medium. Cultures from four of eight patients treated with PAS alone for prolonged periods (90 to 267 days) were able to resist the inhibitory action of PAS at concentrations greatly in excess of that required to inhibit the growth of strains from untreated patients. In a group of 10 patients treated with streptomycin, PAS and promin, only one was found after treatment to have streptomycin-resistant tubercle bacilli and one other had PAS-resistant tubercle bacilli.
[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].

L. Baving,M. Schmidt

Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie

Abstract:OBJECTIVES Focal issues of recent research on obsessive-compulsive disorders have been the involvement of the frontostriatal system in the patho-physiology, as well as the manner of effect and efficacy of the serotonin reuptake inhibitors that unfold their specific efficacy in the frontostriatal system. The course of treatment among adolescent inpatients with obsessive-compulsive disorder was analyzed with regard to the medications used and their effects upon the course of treatment. METHODS The data for all adolescents with obsessive-compulsive disorder admitted as inpatients to the Hospital for Child and Adolescent Psychiatry and Psychotherapy in Mannheim since 01.01.1990 were analyzed with regard to medication and the parameters for course and outcome. RESULTS Five patients dropped out of treatment, five patients received no medication, eight received sulpiride, ten were treated with clomipramine, and three with fluvoxamine. The average length of inpatient stay was longer for the groups treated with sulpiride and clomipramine than for the group that received no medication, but equivalent for these two medication groups. The success of treatment for obsessive-compulsive disorder was rated as higher in these two groups than in the group without medication. On sulpiride, patients gained weight and exhibited fatigue and increased levels of prolactin. On clomipramine, half of the patients exhibited cardiac side effects. CONCLUSIONS This small, nonrandomized medicated sample analyzed under non-double-blind conditions shows no difference in the efficacy of clomipramine and sulpiride under post hoc analysis. Rather, the side effects that occurred in patients on clomipramine indicate a more frequent use of SSRI to increase compliance as regards medication intake.
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys

Sofia Pavanello,Manuela Campisi,Paolo Rigotti,Marianna Di Bello,Erica Nuzzolese,Flavia Neri,Lucrezia Furian

DOI: https://doi.org/10.3389/fmed.2022.832411

IF: 3.9

2022-03-23

Frontiers in Medicine

Abstract:The biological age of an organ may represent a valuable tool for assessing its quality, especially in the elder. We examined the biological age of the kidneys [right (RK) and left kidney (LK)] and blood leukocytes in the same subject and compared these to assess whether blood mirrors kidney biological aging. Biological age was studied in n = 36 donors (median age: 72 years, range: 19–92; male: 42%) by exploring mitotic and non-mitotic pathways, using telomere length (TL) and age-methylation changes (DNAmAge) and its acceleration (AgeAcc). RK and LK DNAmAge are older than blood DNAmAge (RK vs. Blood, p = 0.0271 and LK vs. Blood, p = 0.0245) and RK and LK AgeAcc present higher score (this mean the AgeAcc is faster) than that of blood leukocytes ( p = 0.0271 and p = 0.0245) in the same donor. TL of RK and LK are instead longer than that of blood ( p = 0.0011 and p = 0.0098) and the increase in Remuzzi-Karpinski score is strongly correlated with kidney TL attrition ( p = 0.0046). Finally, blood and kidney TL ( p < 0.01) and DNAmAge ( p < 0.001) were correlated. These markers can be evaluated in further studies as indicators of biological age of donor organ quality and increase the usage of organs from donors of advanced age therefore offering a potential translational research inkidney transplantation.

medicine, general & internal
Altered DNA methylation is associated with aberrant gene expression in parenchymal but not airway fibroblasts isolated from individuals with COPD

Rachel L. Clifford,Nick Fishbane,Jamie Patel,Julia L. MacIsaac,Lisa M. McEwen,Andrew J. Fisher,Corry-Anke Brandsma,Parameswaran Nair,Michael S. Kobor,Tillie-Louise Hackett,Alan J. Knox

DOI: https://doi.org/10.1186/s13148-018-0464-5

2018-03-05

Clinical Epigenetics

Abstract:BackgroundChronic obstructive pulmonary disease (COPD) is a heterogeneous disease of the lungs that is currently the fourth leading cause of death worldwide. Genetic factors account for only a small amount of COPD risk, but epigenetic mechanisms, including DNA methylation, have the potential to mediate the interactions between an individual’s genetics and environmental exposure. DNA methylation is highly cell type-specific, and individual cell type studies of DNA methylation in COPD are sparse. Fibroblasts are present within the airway and parenchyma of the lung and contribute to the aberrant deposition of extracellular matrix in COPD. No assessment or comparison of genome-wide DNA methylation profiles in the airway and parenchymal fibroblasts from individuals with and without COPD has been undertaken. These data provide valuable insight into the molecular mechanisms contributing to COPD and the differing pathologies of small airways disease and emphysema in COPD.MethodsGenome-wide DNA methylation was evaluated at over 485,000 CpG sites using the Illumina Infinium HumanMethylation450 BeadChip array in the airway (non-COPD n = 8, COPD n = 7) and parenchymal fibroblasts (non-COPD n = 17, COPD n = 29) isolated from individuals with and without COPD. Targeted gene expression was assessed by qPCR in matched RNA samples.ResultsDifferentially methylated DNA regions were identified between cells isolated from individuals with and without COPD in both airway and parenchymal fibroblasts. Only in parenchymal fibroblasts was differential DNA methylation associated with differential gene expression. A second analysis of differential DNA methylation variability identified 359 individual differentially variable CpG sites in parenchymal fibroblasts. No differentially variable CpG sites were identified in the airway fibroblasts. Five differentially variable-methylated CpG sites, associated with three genes, were subsequently assessed for gene expression differences. Two genes (OAT and GRIK2) displayed significantly increased gene expression in cells isolated from individuals with COPD.ConclusionsDifferential and variable DNA methylation was associated with COPD status in the parenchymal fibroblasts but not airway fibroblasts. Aberrant DNA methylation was associated with altered gene expression imparting biological function to DNA methylation changes. Changes in DNA methylation are therefore implicated in the molecular mechanisms underlying COPD pathogenesis and may represent novel therapeutic targets.

oncology,genetics & heredity
Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease

Ana I Hernández Cordero,Chen Xi Yang,Julia Yang,Tawimas Shaipanich,Julia MacIsaac,Silvia Guillemi,Marianne Harris,Wan Lam,Stephen Lam,Julio Montaner,S F Paul Man,Don D Sin,Janice M Leung,Steven Horvath,David TS Lin,Michael S. Kobor

DOI: https://doi.org/10.1164/rccm.202106-1440oc

IF: 24.7

2022-04-15

American Journal of Respiratory and Critical Care Medicine

Abstract:Rationale: Age-related diseases like chronic obstructive pulmonary disease (COPD) occur at higher rates in people living with human immunodeficiency virus (PLWH) than in uninfected populations. Objectives: To identify whether accelerated aging can be observed in the airways of PLWH with COPD, manifest by a unique DNA methylation signature. Methods: Bronchial epithelial brushings from PLWH with and without COPD and HIV-uninfected adults with and without COPD (N = 76) were profiled for DNA methylation and gene expression. We evaluated global Alu and LINE-1 methylation and calculated the epigenetic age using the Horvath clock and the methylation telomere length estimator. To identify genome-wide differential DNA methylation and gene expression associated with HIV and COPD, robust linear models were used followed by an expression quantitative trait methylation (eQTM) analysis. Measurements and Main Results: Epigenetic age acceleration and shorter methylation estimates of telomere length were found in PLWH with COPD compared with PLWH without COPD and uninfected patients with and without COPD. Global hypomethylation was identified in PLWH. We identified 7,970 cytosine bases located next to a guanine base (CpG sites), 293 genes, and 9 expression quantitative trait methylation-gene pairs associated with the interaction between HIV and COPD. Actin binding LIM protein family member 3 (ABLIM3) was one of the novel candidate genes for HIV-associated COPD highlighted by our analysis. Conclusions: Methylation age acceleration is observed in the airway epithelium of PLWH with COPD, a process that may be responsible for the heightened risk of COPD in this population. Their distinct methylation profile, differing from that observed in patients with COPD alone, suggests a unique pathogenesis to HIV-associated COPD. The associations warrant further investigation to establish causality.

respiratory system,critical care medicine
Lung tissue gene-expression signature for the ageing lung in COPD

Maaike de Vries,Alen Faiz,Roy R Woldhuis,Dirkje S Postma,Tristan V de Jong,Don D Sin,Yohan Bossé,David C Nickle,Victor Guryev,Wim Timens,Maarten van den Berge,Corry-Anke Brandsma

DOI: https://doi.org/10.1136/thoraxjnl-2017-210074

2017-12-06

Thorax

Abstract:Introduction COPD is a chronic, progressive, inflammatory disease of the lungs and the third leading cause of death worldwide. The current knowledge of the pathophysiology of COPD is limited and novel insights in underlying disease mechanisms are urgently needed. Since there are clear parallels between ageing and COPD, we investigated genes underlying lung ageing in general and abnormal lung ageing in COPD. Methods Whole genome mRNA profiling was performed on lung tissue samples (n=1197) and differential gene expression with increasing age was analysed using an adjusted linear regression model. Subsequent pathway analysis was performed using GeneNetwork and the gene-expression signature was compared with lung ageing in the Genotype-Tissue Expression (GTEx) project. In a subset of patients with COPD (n=311) and non-COPD controls (n=270), we performed an interaction analysis between age and COPD to identify genes differentially expressed with age in COPD compared with controls, followed by gene set enrichment pathway analysis. Results We identified a strong gene-expression signature for lung ageing with 3509 differentially expressed genes, of which 33.5% were found nominal significant in the GTEx project. Interestingly, we found EDA2R as a strong candidate gene for lung ageing. The age*COPD interaction analysis revealed 69 genes significantly differentially expressed with age between COPD and controls. Conclusions Our study indicates that processes related to lung development, cell-cell contacts, calcium signalling and immune responses are involved in lung ageing in general. Pathways related to extracellular matrix, mammalian target of rapamycin signalling, splicing of introns and exons and the ribosome complex are proposed to be involved in abnormal lung ageing in COPD.

respiratory system
Associations Between Long-Term Exposure to PM2.5 Component Species and Blood DNA Methylation Age in the Elderly: the VA Normative Aging Study

Jamaji C. Nwanaji-Enwerem,Lingzhen Dai,Elena Colicino,Youssef Oulhote,Qian Di,Itai Kloog,Allan C. Just,Lifang Hou,Pantel Vokonas,Andrea A. Baccarelli,Marc G. Weisskopf,Joel D. Schwartz

DOI: https://doi.org/10.1016/j.envint.2016.12.024

IF: 11.8

2017-01-01

Environment International

Abstract:Background: Long-term PM2.5 exposure and aging have been implicated in multiple shared diseases; studying their relationship is a promising strategy to further understand the adverse impact of PM2.5 on human health.Objective: We assessed the relationship of major PM2.5 component species (ammonium, elemental carbon, organic carbon, nitrate, and sulfate) with Horvath and Hannum DNA methylation (DNAm) age, two DNA methylation-based predictors of chronological age.Methods: This analysis included 552 participants from the Normative Aging Study with multiple visits between 2000 and 2011 (n = 940 visits). We estimated 1-year PM2.5 species levels at participants' addresses using the GEOS-chem transport model. Blood DNAm-age was calculated using CpG sites on the Illumina HumanMethylation450 BeadChip. We fit linear mixed-effects models, controlling for PM2.5 mass and lifestyle/environmental factors as fixed effects, with the adaptive LASSO penalty to identify PM2.5 species associated with DNAm-age.Results: Sulfate and ammonium were selected by the LASSO in the Horvath DNAm-age models. In a fully-adjusted multiple-species model, interquartile range increases in both 1-year sulfate (95%CI: 0.28, 0.74, P < 0.0001) and ammonium (95%CI: 0.02, 0.70, P = 0.04) levels were associated with at least a 0.36-year increase in Horvath DNAm-age. No PM2.5 species were selected by the LASSO in the Hannum DNAm-age models. Our findings persisted in sensitivity analyses including only visits with 1-year PM2.5 levels within US EPA national quality standards.Conclusion: Our results demonstrate that sulfate and ammonium were most associated with Horvath DNAm-age and suggest that DNAm-age measures differ in their sensitivity to ambient particle exposures and potentially disease. Published by Elsevier Ltd.
Expression of Long Noncoding RNAs and Protein-Coding Genes Involved in Oxidative Stress and Cell Senescence in Patients with Chronic Obstructive Pulmonary Disease

V. A. Markelov,G. F. Korytina,Y. G. Aznabaeva,I. A. Gibadullin,L. Z. Akhmadishina,T. R. Nasibullin,O. V. Kochetova,A. M. Avzaletdinov,N. Sh. Zagidullin

DOI: https://doi.org/10.1134/s0026893324700481

2024-10-16

Molecular Biology

Abstract:Chronic obstructive pulmonary disease (COPD) is a multifactorial heterogeneous chronic inflammatory respiratory disease. The molecular pathogenesis of COPD may include dysregulation of the stress responses that are associated with cell senescence and involve a wide range of signaling pathways and their epigenetic regulators, such as long noncoding RNAs (lncRNAs). To assess the contribution of genes involved in key signaling pathways related to cell senescence to the molecular pathogenesis of COPD, expression profiling of lncRNA ( TP53TG1 , LINC00342 , H19 , MALAT1 , DNM3OS , and MEG3 ) and protein-coding ( PTEN , TGFB2 , FOXO3 , and KEAP1 ) genes was performed in peripheral blood mononuclear cells of COPD patients ( n = 92) and control subjects ( n = 81). Significant downregulation of the TP53TG1 and DNM3OS lncRNAs and the TGFB2 mRNA was observed in the COPD patients, while the MALAT1 and LINC00342 were upregulated. A highly informative prognostic model was constructed based on the multiple regression and ROC analyses. The model included simultaneous assessment of the TP53TG1 and TGFB2 expression levels (AUC = 0.92). MALAT1 , DNM3OS , TGFB2 , FOXO3 and KEAP1 expression levels were found to positively correlate with lung function parameters, reflecting the disease progression. The lncRNA ( TP53TG1 , LINC00342 , DNM3OS , and MALAT1 ) and protein-coding ( TGFB2 ) genes that were differentially expressed in the COPD patients are functionally involved in regulating apoptosis, inflammation, fibrogenesis, and the epithelial-to-mesenchymal transition, implicating cell senescence processes in the molecular pathogenesis of COPD.

biochemistry & molecular biology
Association of Polymorphic Loci of Long Noncoding RNA Genes (H19, MEG3, MALAT1, LINC00305, LINC00261, LINC02227, and CDKN2B-AS1) with Chronic Obstructive Pulmonary Disease

G. F. Korytina,L. Z. Akhmadishina,V. A. Markelov,T. R. Nasibullin,Y. G. Aznabaeva,O. V. Kochetova,N. N. Khusnutdinova,A. P. Larkina,N. Sh. Zagidullin,T. V. Victorova

DOI: https://doi.org/10.1134/s1022795424700777

2024-10-01

Russian Journal of Genetics

Abstract:Chronic obstructive pulmonary disease (COPD) is a chronic lung disease resulting from dynamic, cumulative gene-environment interactions that cause lung tissue injury, alteration of its normal function, and acceleration of cellular senescence. Long noncoding RNAs (lncRNAs) function as critical epigenetic regulators of various aspects of cellular senescence. The objective of the present study is to identify the association between polymorphic variants of H19 (rs3741219), MEG3 (rs7158663), MALAT1 (rs619586), LINC00305 (rs2850711), LINC00261 (rs6048205), CDKN2B-AS1 (rs4977574), and LINC02227 (rs2149954) lncRNAs genes with COPD. DNA samples from COPD patients ( N = 703) and healthy individuals ( N = 655) were studied in this study and polymorphic loci were analyzed by real-time PCR. Association with COPD was established with H19 (rs3741219), MEG3 (rs7158663), LINC02227 (rs2149954), MALAT1 (rs619586) and CDKN2B-AS1 (rs4977574). Polygenic analysis has made it possible to identify informative gene–gene combinations that include polymorphic variants of the studied lncRNAs genes and genes encoding molecules of signaling cascades associated with cellular senescence and apoptosis. Multiple regression and ROC analysis revealed a COPD risk predictive model, which included gene–gene combinations of lncRNAs genes and smoking index ( P = 4.01 × 10 –48 , AUC = 0.87).

genetics & heredity
ACETOACETATE FORMATION IN LIVER ON THE

G.,W.,Brown,H.,R.,Matheson

DOI: https://doi.org/10.1016/s0021-9258(18)56064-6

Abstract:
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients

Patrizia Russo,Francesca Milani,Antonio De Iure,Stefania Proietti,Dolores Limongi,Carla Prezioso,Paola Checconi,Vincenzo Zagà,Federica Novazzi,Fabrizio Maggi,Guido Antonelli,Stefano Bonassi

DOI: https://doi.org/10.3390/ijms25115834

IF: 5.6

2024-05-28

International Journal of Molecular Sciences

Abstract:Cigarette smoking is a primary contributor to mortality risks and is associated with various diseases. Among these, COPD represents a significant contributor to global mortality and disability. The objective of this study is to investigate the effect of smoking on a selected battery of variables, with an emphasis on DNA damage. A total of 87 elderly patients diagnosed with COPD, divided into three groups based on their smoking history (current, former, never-smokers), were evaluated using a cross-sectional approach. Clinical features including mortality and inflammatory/oxidative parameters (Lymphocytes/Monocytes, Neutrophils/Lymphocytes, Platelets/Lymphocytes ratio), SII, MDA, 8-Oxo-dG, and IL6 (ELISA assay), as well as DNA damage (comet assay), were investigated. Virus infection, i.e., influenza A virus subtype H1N1, JC polyomavirus (JCPyV), BK polyomavirus (BKPyV), and Torquetenovirus (TTV), was also tested. Current smokers exhibit higher levels of comorbidity (CIRS; p < 0.001), Platelets/Lymphocytes ratio (p < 0.001), systemic immune inflammation (p < 0.05), and DNA damage (p < 0.001). Former smokers also showed higher values for parameters associated with oxidative damage and showed a much lower probability of surviving over 5 years compared to never- and current smokers (p < 0.0017). This study showed a clear interaction between events which are relevant to the oxidative pathway and cigarette smoking. A category of particular interest is represented by former smokers, especially for lower survival, possibly due to the presence of more health problems. Our findings raise also the attention to other parameters which are significantly affected by smoking and are useful to monitor COPD patients starting a program of pulmonary rehabilitation (DNA damage, inflammation parameters, and selected viral infections).

biochemistry & molecular biology,chemistry, multidisciplinary

[1-(2-hydroxyethyl)-1,2,4-triazole esters].

LSC - 2024 - Epigenetic age acceleration and severity of airflow limitation on blood and lung tissue of COPD

Epigenetic blood biomarkers of ageing and mortality in COPD

The Blood DNA Methylation Clock GrimAge Is a Robust Surrogate for Airway Epithelia Aging

Epigenome-wide Gene–age Interaction Analysis Reveals Reversed Effects of PRODH DNA Methylation on Survival Between Young and Elderly Early-Stage NSCLC Patients

Cell-free DNA levels associate with COPD exacerbations and mortality

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease

The influence of chronic inflammation in COPD patients aged 40 to 60 years on the early development of atherosclerotic changes in brachiocephalic vessels.

Neutrophil-to-Lymphocyte Ratio, Lung Function, COPD, and AHRR Hypomethylation in Older Adults: A 30-Year Longitudinal Study of US Veterans

Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies

The occurrence of tubercle bacilli resistant to P-aminosalicylic acid.

[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].

DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys

Altered DNA methylation is associated with aberrant gene expression in parenchymal but not airway fibroblasts isolated from individuals with COPD

Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease

Lung tissue gene-expression signature for the ageing lung in COPD

Associations Between Long-Term Exposure to PM2.5 Component Species and Blood DNA Methylation Age in the Elderly: the VA Normative Aging Study

Expression of Long Noncoding RNAs and Protein-Coding Genes Involved in Oxidative Stress and Cell Senescence in Patients with Chronic Obstructive Pulmonary Disease

Association of Polymorphic Loci of Long Noncoding RNA Genes (H19, MEG3, MALAT1, LINC00305, LINC00261, LINC02227, and CDKN2B-AS1) with Chronic Obstructive Pulmonary Disease

ACETOACETATE FORMATION IN LIVER ON THE

Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients